It has been reported that some flavonoids, including naringin, apigenin, and rutin, are able to inhibit VEGF release in MDA human breast cancer cells [173], and VEGF and transforming growth factor-β1 (TGF-β1) in the GL-15 glioblastoma cell lines [174]. This evidence concerns the gene VEGFA and breast cancer.